Chimera Bioengineering Company
Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.
Technology:
Cell therapy, Neurological Disorders
Industry:
PharmTech, Private
Headquarters:
South San Francisco, California, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Investors Number:
5
Total Funding:
30700284
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-04-28
Last Funding Type:
Grant
Register and Claim Ownership